Europe Animal Healthcare Market, By Drug Type, By Animal Type, By Indication

Description

Global Europe Animal Healthcare Market is estimated to be valued at USD 16,081.2 Mn in 2025 and is expected to reach USD 23,099.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 16,081.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 23,099.6 Mn

Figure. Europe Animal Healthcare Market Share (%), By Drug Type 2025

The animal healthcare market in Europe is expected to grow at a significant rate over the next decade. There is growing awareness among pet owners regarding animal wellness and preventive healthcare. Pet insurance and growing expendable income have enabled owners to spend more on vet care and services. Furthermore, advancements in veterinary medicines and diagnostic technologies have improved treatment outcomes for various animal illnesses and diseases. Various regions in Europe have also implemented stringent regulations regarding animal welfare and standards of care, contributing to market expansion. Overall, the improving economic conditions and changing consumer attitudes toward pets will likely drive the animal healthcare industry in the European region.

Market Dynamics:

The Europe animal healthcare market is witnessing robust growth driven by several factors. Rising pet adoption in countries such as the U.K., Germany, and France due to changing social trends has augmented the demand for vaccination, pharmaceuticals, and diagnostic services. Additionally, growing pet insurance penetration providing coverage for vet expenses has encouraged owners to utilize preventive healthcare regularly. Furthermore, launch of novel pet care products and rapid approval of veterinary drugs are supporting the treatment of various diseases. However, strict regulations surrounding the approval and use of animal drugs pose a challenge. Moreover, high costs associated with R&D of animal health solutions restrain market growth. Nonetheless, increasing awareness about zoonotic diseases presents lucrative opportunities for key players.

Key Features of the Study:

This report provides an in-depth analysis of the Europe animal healthcare market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe animal healthcare market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Merck & Co., Inc., Virbac, Dechra Pharmaceuticals, Vetoquinol S.A., Zoetis Inc., Ceva Sante Animale, Bayer AG, Elanco, Evonik Industries AG, Archer Daniels Midland Company, Cargill, Incorporated, SeQuent Scientific Ltd., Hester Biosciences, and Bioiberica S.A.U
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Europe animal healthcare market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market

Detailed Segmentation-

By Drug Type:
- Anti-Infective Agents
- Anti-Inflammatory & Analgesic Agents
- Parasiticides
- Vaccines
- Hormones & Substitutes
- Others
By Animal Type:
- Livestock
- Bovine
- Porcine
- Poultry
- Other
- Companion
- Canine
- Feline
- Equine
By Indication:
- Infectious Diseases
- Pain Management
- Auto-immune Disease
- Others
Company Profiles:
- Merck & Co., Inc.
- Virbac
- Dechra Pharmaceuticals
- Vetoquinol S.A.
- Zoetis Inc.
- Ceva Sante Animale
- Bayer AG
- Elanco
- Evonik Industries AG
- Archer Daniels Midland Company
- Cargill, Incorporated
- SeQuent Scientific Ltd.
- Hester Biosciences
- Bioiberica S.A.U

Product Code: CMI550

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Animal Type
- Market Snapshot, By Indication
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Technological Advancements
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Europe Animal Healthcare Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Europe Animal Healthcare Market, By Drug Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Anti-Infective Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Anti-Inflammatory & Analgesic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Parasiticides
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hormones & Substitutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Europe Animal Healthcare Market, By Animal Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Livestock
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Bovine
Porcine
Poultry
Other
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Companion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Canine
Feline
Equine

7. Europe Animal Healthcare Market, By Indication, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Auto-immune Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Competitive Landscape

Company Profiles
- Merck & Co., Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Virbac
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dechra Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vetoquinol S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zoetis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ceva Sante Animale
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Evonik Industries AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Archer Daniels Midland Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cargill, Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- SeQuent Scientific Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hester Biosciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bioiberica S.A.U
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies

9. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us and Sales Contact